Clinical trials
Recruiting Fatty Liver trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | 1 |
| Beijing Friendship Hospital | 1 |
| Beijing Jishuitan Hospital | 1 |
| Chongqing Medical University | 1 |
| Eli Lilly and Company | 1 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 1 |
| Hinova Pharmaceuticals Inc. | 1 |
| Hudson Biotech | 1 |
| Jinling Hospital, China | 1 |
| The Affiliated Hospital of Xuzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 11 |
| Non-alcoholic Fatty Liver Disease | 5 |
| Obesity | 3 |
| Fibrosis | 2 |
| Liver Cirrhosis | 2 |
| Overweight | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Disease Progression | 1 |
| Inflammation | 1 |
| Liver Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.